News And EVENTS
Stay up to date with our latest news and see where you can find us next.
Ex vivo human skin tissue models are transforming dermatology drug development by providing highly predictive, human-relevant data for safety, efficacy, and mechanism of action studies.
Melanin inhibition testing using human melanocytes provides quantitative, reproducible data to evaluate ingredient performance, optimize formulations, and support scientifically backed efficacy claims.
Nearly 90% of clinical drug development programs fail, often due to preventable safety and efficacy issues. Pharmaceutical sponsors are turning to patient genotyping to reduce risk earlier in clinical trials.
Explore hair care’s skinification, the rising recognition of the scalp as the foundation for healthy hair, and the role of biomarker testing.
Longevity-focused skincare marks a fundamental shift away from surface-level anti-aging claims toward formulations built on measurable biology
the molecular pathways that drive skin aging, resilience, and repair. From uncovering mechanisms of action to generating science-backed claim support, biomarker analysis provides the evidence needed to develop longevity products that stand apart in an increasingly data-driven skincare market.
As consumer demand for science-backed supplements grow, nutraceutical testing with biomarker analysis helps brands validate efficacy, ensure safety, and build trust.
Meso Scale Discovery (MSD) is a high-sensitivity, multiplexed immunoassay platform that transforms biomarker analysis in drug development. Learn what MSD is, how it works, when to use Meso Scale Discovery, and how MSD vs ELISA compares for detecting low-abundance proteins, conserving sample material, and accelerating preclinical and clinical research.
Contact the GENEMARKERS Team
Have questions? Interested in learning more about how Genemarkers can help? Fill out the form below and a member of our team will reach out shortly.